Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PreOperative Endocrine Therapy for Individualised Care with Abemaciclib
2019-003897-24Phase 3Unknown
- Sponsor
- The Institute of Cancer Research
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of abemaciclib in breast cancer (2 arms), sponsored by The Institute of Cancer Research. Primary endpoint: Time to tumour recurrence. Status: unknown.
02
Drugs
abemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2019-003897-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003897-24.